Biosys Technologies P Limited Company Profile

09:06 EST 18th November 2017 | BioPortfolio


· Established in the year 2001.

· Corporate Office at Bangalore.

· Branches at Chennai & Mangalore.

· Associate Overseas Offices in USA & Singapore.

· Lead by a Team of Technocrats.

· Supported by over 100 Trained Professionals.

· Association with Leaders in Respective Fields.


· Adopt a Systematic Approach.

· Provide Standard-based solution.

· Enable State-of-art implementation.

· Future-proof solutions.

· Support Existing Technologies.

· Migration Path to Emerging Technologies.

· Adapt to Client Requirements.

· Provide Quality Support Services.

· Ensure minimum downtime.

· Provide Investment Protection.


· R&D in the field of Bioinformatics

· Software Development

· Training in the field of Bioinformatics

· Communication Systems

· Call Center Solutions


· Director Overseas-Dr .M. Sanjay Kanth

- M.B.B.S, M.P.H.

- Graduate from Bangalore University.

- Gold medallist in academics.

- Innovative and Service oriented.

- Innovative Technical Expertise in Special Projects.

· C.E.O- Mr. M. Sujay Kanth

- Mechanical Engineer by Profession and MBA.

- Specialized in Network Management.

- Six years of project management experience.

· M.D – Mr. Alluri Himavardhana Naidu

- Automobile Engineer from Karnataka University, Dharwad

- M.B.A

- Worked as a Senior Managerial positions, as Manager, Engineer, Maintenance Engineer, for 10 yrs in K.S.R.T.C.

- Member in Indian Institute of Road Transport.

- Member and Vice President of Indian Institute of Automobile Engineers, Hubli.


· Dr. S. Parameswaram. Ph. D Power controls

Director (Retd), C.P.R.I.

- 30 years experience in field of Engineering and Research

· Dr. .H .S. Anantha Padmanabha PhD Life sciences

- 35 years of experience in the field of Sandalwood tissue culture, Bio diversity culture.

· Dr. V Srikrishna MSC, MBA

- PhD Botany, PhD Environmental Sciences.

- 20 years of experience in Aquaculture



Annapoorneswari Towers, # 125/31 11th main 33rd Cross Jaynagar IV Block
560 011


Phone: 91-80-6557704 and 91-80-6559911
Fax: 91-80-6557704

News Articles [223 Associated News Articles listed on BioPortfolio]

Biosys Appoints Axel Wiest to Board of Directors

London, UK, 14th February 2017 / Sciad Newswire / Biosys UK Limited (“Biosys” or the “Company”), a clinical-stage microbiome company dedicated to the development of targeted oral immune ther...

Jubilant Biosys Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12102017] Prices from USD $250

SummaryJubilant Biosys Ltd Jubilant Biosys, a subsidiary of Jubilant Life Sciences Ltd is a provider of drug discovery and development solutions to the pharmaceutical industry. The company's functiona...

Appointment of Director

Oxford, UK, 1 November 2017: e-Therapeutics plc (AIM: ETX), a company pioneering the use of Network-Driven Drug Discovery (NDD) to create new and better drugs, announces the appointment of Christine...

Telix Pharmaceuticals Limited Lists on the Australian Securities Exchange

MELBOURNE, Australia, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the developmen...

Oncobiologics announces strategic partnership with GMS Tenshi Holdings Pte. Limited

CRANBURY, N.J., Sept. 08, 2017 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS) today announced that it entered into a Purchase Agreement on September 7, 2017 with GMS Tenshi Holdings Pte. Li...

Quotient Limited Reports Second Quarter Fiscal 2018 Financial Results

MosaiQ project de-risked, Verification and Validation (“V&V”) “head-to-head” studies confirm targeted concordance levels for all blood grouping assaysEuropean field trials planned to co...

Quotient Limited to Participate in the Jefferies 2017 London Healthcare Conference

JERSEY, Channel Islands, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Execut...

Quotient Limited to Participate in the Cantor Fitzgerald 2017 Global Healthcare Conference

JERSEY, Channel Islands, Sept. 13, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive...

PubMed Articles [333 Associated PubMed Articles listed on BioPortfolio]

Health technology assessments conducted in health care facilities: A strategic practice? Findings from a content analysis of HTA reports.

In this paper, we test the hypothesis that health technology assessment units located in hospitals tend to be more optimistic toward technologies that are currently in use in their organization than t...

Enhancing the Gaming Experience Using 3D Spatial User Interface Technologies.

Three-dimensional (3D) spatial user interface technologies have the potential to make games more immersive and engaging and thus provide a better user experience. Although technologies such as stereos...

A brief review of single-cell transcriptomic technologies.

In recent years, there has been an effort to develop new technologies for measuring gene expression and sequence information from thousands of individual cells. Large data sets that were obtained usin...

Technologies to Support Community-Dwelling Persons With Dementia: A Position Paper on Issues Regarding Development, Usability, Effectiveness and Cost-Effectiveness, Deployment, and Ethics.

With the expected increase in the numbers of persons with dementia, providing timely, adequate, and affordable care and support is challenging. Assistive and health technologies may be a valuable cont...

3D Metal Printing - Additive Manufacturing Technologies for Frameworks of Implant-Borne Fixed Dental Prosthesis.

An edentulous patient was rehabilitated with maxillary metal-ceramic and mandibular metal-resin implant-supported fixed dental prosthesis (FDP). Metal frameworks of the FDPs were fabricated using 3D a...

Clinical Trials [329 Associated Clinical Trials listed on BioPortfolio]

Application of Monitoring and Intervention Technologies in Suboptimal Health Status

The purpose of this study is to use monitoring and intervention technologies in suboptimal health status in a general population in China and evaluate the effectiveness of these technologi...

Wheeze Detection in Adults During Dynamic Bronchial Situations Measured by PulmoTrack® 2010 With WIM-PC™ Technologies Recording

The PulmoTrack® 2010 with WIM-PC™ Technologies device, indicated for acoustic pulmonary function measurement that quantifies the presence of wheezing. This study was designed in order t...

Testing Latest Version of NidekRS3000Adv

The investigators would like to know if different imaging devices can improve the quality of images and visualization of imaged tissues. Also, the investigators would like to find out whet...

Objective Functional Outcome Measures in Orthopedic Surgery Using Advanced Tracking Technologies

The proposed project will address the measurement and ramifications of out-of-home mobility problems in various orthopedic disorders in an innovative way, using advanced tracking technolog...

Online Peer Networked Collaborative Learning for Managing Depressive Symptoms

The mission of this project is to develop novel systems of care that can provide efficacious, scalable, cost-effective, participant friendly technology assisted behavioral interventions (T...

Companies [1316 Associated Companies listed on BioPortfolio]

Jubilant Biosys Ltd

Jubilant Biosys Ltd. (JBL) (, a subsidiary of Jubilant Organosys Ltd., provides integrated drug discovery and development solutions to the global pharmaceutical industry. Ju...

Jubilant Organosys Ltd

Jubilant Biosys Ltd. is a subsidiary of Jubilant Organosys Ltd., which provides integrated drug discovery and development solutions to the global pharmaceutical industry. The 120,000 sq. ft. state...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

Circadian Technologies Limited

Circadian Technologies Limited is an emerging leader in the field of angiogenesis-based treatments for cancer. Focusing on a class of drug targets called Vascular Endothelial Growth Factors (VEGFs),...

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...

More Information about "Biosys Technologies P Limited" on BioPortfolio

We have published hundreds of Biosys Technologies P Limited news stories on BioPortfolio along with dozens of Biosys Technologies P Limited Clinical Trials and PubMed Articles about Biosys Technologies P Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Biosys Technologies P Limited Companies in our database. You can also find out about relevant Biosys Technologies P Limited Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record